The National Institutes of Health announced 93 awards to fund highly innovative, high-impact biomedical research as part of its High-Risk, High-Reward Research Program.
UNC Gillings School of Global Public Health researcher Lisa LaVange, PhD, is the PI of an NIH HEAL Initiative project to help people with chronic back pain and to curb opioid misuse. It includes Tim Carey, MD, MPH; Tim Platts-Mills, MD, MSc; and Sam McLean, MD, from the UNC School of Medicine.
The UNC School of Medicine lab of Ben Philpot, PhD, will build upon research previously funded by the Pitt-Hopkins Research Foundation to develop a therapy to treat children with this neurodevelopmental disorder.
UNC Lineberger Comprehensive Cancer Center researchers led by Chad Pecot, MD, published new findings that help explain one path that breast cancers can take as they leave tumors and spread throughout the body.
A new study, led by Lauren Brinkley-Rubinstein, PhD, in the UNC department of social medicine, finds that people who were held in restrictive housing while serving time in prison face a substantial increased risk of death after their release.
Seema Garg, MD, PhD, is leading a study that uses telemedicine and new imaging technology to offer a convenient retinal screening method for patients with diabetes at risk for vision loss. Tom Miller, MD, is integrating the innovative technology into UNC’s clinical setting.
The National Cancer Institute has awarded University of North Carolina Lineberger Comprehensive Cancer Center researcher Adam Goldstein, MD, MPH, a five-year, $2.7 million grant to develop more effective health warnings for little cigars and cigarillos.
Researchers led by Ron Swanstrom, PhD, and colleagues in South Africa, discovered that the latent HIV reservoir that persists during antiretroviral treatment mostly reflects viruses present in the blood at the start of antiretroviral treatment.
Formed 15 years ago, the Genetic Disorders of Mucociliary Clearance Consortium is now co-led by UNC’s Stephanie Davis, MD, to continue advancing knowledge and treatments for genetic chronic pulmonary conditions.
Thomas Kash, PhD, was recognized by the Society for Neuroscience for his "creative research on the neural basis of addiction-related behaviors and its illumination of potential paths forward for understanding and treating the pathological behaviors associated with addiction."
Sameer Arora, MD, a UNC School of Medicine cardiology fellow, is leading a study reviewing hospitalizations for a certain type of heart attack in two hospitals in northern India. This is the first prospective cohort study of this magnitude in the region and is already providing unique data about opportunities to improve STEMI management in India.
The Multicenter AIDS Cohort Study / Women’s Interagency HIV Study Combined Cohort Study is a collaborative research effort to understand and reduce the impact of chronic health conditions that affect people living with HIV. Adaora Adimora, MD, MPH, leads the UNC-Chapel Hill site, one of 13 across the country.
The David and Lucile Packard Foundation announced the 2019 class of Packard Fellow for Science and Engineering, including Wesley Legant, PhD, in the biomedical engineering and pharmacology departments.
By claiming your profile on Doximity by Oct. 31, you’ll be eligible to vote in the 2020 survey that factors into the hospital and specialty rankings in the annual US News and World Report “Best Hospitals” rankings.
Adam Belanger, MD, and fellow interventional pulmonologists, are now offering bronchoscopic long-term reduction for qualifying patients as an alternative to traditional lung volume reduction surgery.
This fall marks 10 years since the opening of the North Carolina Cancer Hospital, a state-of-the-art cancer center built by the people of North Carolina for the people.
UNC Lineberger’s Stephanie Wheeler, PhD, MPH, and Donald Rosenstein, MD, will use the grant to connect cancer patients with potential financial support resources in Carteret, Dare, Jackson, Lenoir, and Nash counties.
The awards honor oncology nurses, allied health professionals, and administrative staff for exceptional care of and devotion to individuals with cancer and their families and to the oncology profession.
“Stop The Bleed” (STB) is a nationwide initiative focused on teaching the basic techniques of bleeding control. Student Interdepartmental “Stop The Bleed” Interest Group Co-founder and instructor Elexis Hollingsworth led the week-long workshop for School of Medicine students.
Led by UNC Family Medicine and UNC Lineberger researchers, a systematic review of scientific literature revealed the role flavored e-cigarettes have on product preference, appeal, harm perceptions, willingness to use, and initiation among youth. Flavors similarly affect adult e-cigarette use, though the relationship between e-cigarette flavors and cessation of cigarette smoking among adults remains unclear.
University of North Carolina Lineberger Comprehensive Cancer Center researchers have identified a potential approach to stop the growth of the most common type of brain tumor in children.
UNC Lineberger’s Timothy Gershon, MD, PhD, and colleagues have identified a potential approach to stop the growth of the most common type of brain tumor in children. Their research was published in the journal Development.
UNC Lineberger researchers led by Jen Jen Yeh, MD, vice chair for research in the Department of Surgery, designed a computational method to distinguish cancerous tissue from the surrounding connective tissue and cells known as stroma, as well as from immune cells in the tumor’s environment, to drive personalized treatment strategies for cancer patients.
The study, led by Donna M. Evon, PhD, from UNC’s division of gastroenterology and hepatology, finds no justification for disqualifying patients with chronic hepatitis C from receiving Hep C treatment based on mental health and substance use status.
Improving the lives of mothers, babies, and families was the focus at the Marcé of North America (MONA) 4th Biennial Conference on Perinatal Mental Health. MONA is the regional group of the international Marcé Society— a perinatal mental health research organization.
Mom Genes Fight PPD made its debut last week at the Marcé of North America (MONA) perinatal mental health conference hosted by UNC. The research app, formerly called PPD ACT, along with its website and social media pages, were transformed in an effort to renew interest and participation in the postpartum depression (PPD) genetics study.